alpha/beta-blockad versu beta blockad essenti hypertens black white patient purpos multicent investig efficaci safeti alpha/beta-block labetalol beta beta-block atenolol white black patient essenti hypertens equal number black white patient treatment group white patient labetalol atenolol black patient labetalol atenolol ninety-two patient white black patient essenti hypertens diastol blood pressur mm Hg inclus trial patient labetalol dosag mg/day atenolol dosag mg/day therapeut goal achiev diastol blood pressur mm Hg fall mm Hg diastol pressur baselin valu end placebo run period end studi signific differ blood pressur heart rate chang supin posit labetalol atenolol group contrast labetalol reduct stand systol diastol blood pressur mm Hg atenolol mm Hg decreas blood pressur white patient labetalol black patient decreas blood pressur labetalol atenolol respect systol blood pressur alpha properti labetalol addit lower blood pressur beta stand posit enhanc efficaci radic group 